ARTL
ARTELO BIOSCIENCES, INC.
NASDAQ · Healthcare · Biotechnology · US
$3.94
−0.76%Next report
Analyst consensus
- Next report date
- Nov 17, 2026
- EPS estimate
- -$7.02
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.89
- EPS estimate
- -$0.72
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 9
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -244.6%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.72 | -$0.89 | Miss -23.61% | — |
| May 14, 2026 | -$0.78 | -$4.00 | Miss -412.82% | — |
| Feb 24, 2026 | -$1.57 | -$4.05 | Miss -157.87% | — |
| Nov 12, 2025 | -$0.82 | -$3.97 | Miss -384.15% | — |
| Aug 13, 2025 | -$4.19 | -$5.61 | Miss -33.89% | — |
| Mar 3, 2025 | -$4.44 | -$7.02 | Miss -58.11% | — |
| Nov 13, 2023 | -$4.20 | -$4.98 | Miss -18.57% | — |
| Aug 10, 2023 | -$0.81 | -$0.56 | Beat 30.86% | — |
| May 12, 2022 | -$1.27 | -$0.75 | Beat 40.94% | — |
| Jan 12, 2022 | -$5.40 | -$7.19 | Miss -33.15% | — |
| Nov 29, 2021 | -$8.99 | -$6.30 | Beat 29.92% | — |
| Jul 12, 2021 | -$0.09 | -$8.99 | Miss -9888.89% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 17, 2026